Yvonne L. Eyler

Array ( [id] => 4978017 [patent_doc_number] => 20070219250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Pharmaceutical Compositions of Nateglinide' [patent_app_type] => utility [patent_app_number] => 10/596013 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3829 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219250.pdf [firstpage_image] =>[orig_patent_app_number] => 10596013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120612 [patent_doc_number] => 20070142327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Active compound combinations having insecticidal properties' [patent_app_type] => utility [patent_app_number] => 10/581346 [patent_app_country] => US [patent_app_date] => 2004-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14186 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142327.pdf [firstpage_image] =>[orig_patent_app_number] => 10581346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142674 [patent_doc_number] => 20050118126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Cosmetic hair composition comprising at least one fixing polymer and at least one compound capable of swelling by the action of heat' [patent_app_type] => utility [patent_app_number] => 10/969924 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7372 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118126.pdf [firstpage_image] =>[orig_patent_app_number] => 10969924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997428 [patent_doc_number] => 20050137206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Method for treatment of anxiety and depression' [patent_app_type] => utility [patent_app_number] => 10/969511 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5701 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137206.pdf [firstpage_image] =>[orig_patent_app_number] => 10969511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5235980 [patent_doc_number] => 20070128136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Terrein compound having melanin biosynthesis inhibitors and its preparation' [patent_app_type] => utility [patent_app_number] => 10/596211 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3243 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128136.pdf [firstpage_image] =>[orig_patent_app_number] => 10596211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637038 [patent_doc_number] => 20060068011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Simultaneous encapsulation technique for use in pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/955045 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5843 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068011.pdf [firstpage_image] =>[orig_patent_app_number] => 10955045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5015764 [patent_doc_number] => 20070258972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand' [patent_app_type] => utility [patent_app_number] => 10/571734 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10713 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20070258972.pdf [firstpage_image] =>[orig_patent_app_number] => 10571734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860463 [patent_doc_number] => 20080269313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Prolyl Oligopeptidase Inhibitors Ameliorating Recovery From Brain Trauma' [patent_app_type] => utility [patent_app_number] => 10/563362 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3038 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269313.pdf [firstpage_image] =>[orig_patent_app_number] => 10563362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051920 [patent_doc_number] => 20070032465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha' [patent_app_type] => utility [patent_app_number] => 10/558354 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9025 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032465.pdf [firstpage_image] =>[orig_patent_app_number] => 10558354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5011452 [patent_doc_number] => 20070281931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate' [patent_app_type] => utility [patent_app_number] => 10/558322 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7946 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281931.pdf [firstpage_image] =>[orig_patent_app_number] => 10558322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028982 [patent_doc_number] => 20070270429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Function Inhibitor of Effector Cell' [patent_app_type] => utility [patent_app_number] => 10/555611 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23813 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270429.pdf [firstpage_image] =>[orig_patent_app_number] => 10555611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834319 [patent_doc_number] => 20060246149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Antimicrobial pigments' [patent_app_type] => utility [patent_app_number] => 10/553668 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27207 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246149.pdf [firstpage_image] =>[orig_patent_app_number] => 10553668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938506 [patent_doc_number] => 20050112069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Pharmaceutical composition of a pde4 or pde 3/4 inhibitor and histamine receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/506875 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22638 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112069.pdf [firstpage_image] =>[orig_patent_app_number] => 10506875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189257 [patent_doc_number] => 08183206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Drugs comprising combination of antithrombotic agent with pyrazolone derivative' [patent_app_type] => utility [patent_app_number] => 10/489507 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4966 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183206.pdf [firstpage_image] =>[orig_patent_app_number] => 10489507 [rel_patent_id] =>[rel_patent_doc_number] =>)